Viewing Protocol Section

Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section


Ignite Creation Date: 2024-05-06 @ 7:18 PM
Last Modification Date: 2024-10-26 @ 3:04 PM
Study NCT ID: NCT05963997
Protocol Section: NCT05963997
Start Identification Module Data
Brief Title: A Study of Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HRHER2-negative Breast Cancer
Official Title: A Phase 1b2 Open-label Study of Samuraciclib in Combination With Elacestrant in Participants With Metastatic or Locally Advanced Hormone Receptor-positive and Human Epidermal Growth Factor Receptor 2-negative Breast Cancer
Acronym: SUMIT-ELA
Organization: Carrick Therapeutics Limited
Organization Class: INDUSTRY
Organization Study ID: CT7001_003
Secondary IDs
Secondary ID Type Domain Link
2023-000072-35 EUDRACT_NUMBER EU CTIS None
2023-503846-30-00 REGISTRY None None
Start Status Module Data
Status Verified Date: 2024-08
Overall Status: ACTIVE_NOT_RECRUITING
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Carrick Therapeutics Limited
Lead Sponsor Class: INDUSTRY
Lead Sponsor: Carrick Therapeutics Limited
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload